Blog
PTAB Denies Institution of Two Sarepta IPRs Related to Elevidys®
On November 6, 2025, the Patent Trial and Appeal Board (“Board”) issued decisions denying institution of Sarepta Therapeutics’ IPR2025-01194 against claims 3-6 of Genzyme’s U.S. Patent No. 9,051,542 (“the ’542 patent) and IPR2025-01195 against claims 1-4, 6-7 and 11 of U.S. Patent No. 7,704,721 (“the ’721 patent”)….
By: Venable LLP